We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Larimar Therapeutics Inc | NASDAQ:LRMR | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
7.00 | 7.99 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | -36.95M | -0.5791 | -1.71 | 63.16M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
13:00:00 | 60 | 7.34 | USD |
Date | Time | Source | Headline |
---|---|---|---|
25/7/2023 | 18:06 | DJN | Larimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 Trial |
Larimar Therapeutics (LRMR) Share Charts1 Year Larimar Therapeutics Chart |
|
1 Month Larimar Therapeutics Chart |
Intraday Larimar Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions